Desjardins Global Asset Management’s Elevance Health ELV Stock Holding History

Desjardins Global Asset Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$1.85M	Buy	3,922 +44	+1%	+$20.3K	0.2%	123
2023 Q3	$1.69M	Buy	3,878 +355	+10%	+$161K	0.18%	127
2023 Q2	$1.57M	Buy	3,523 +256	+8%	+$118K	0.18%	134
2023 Q1	$1.5M	Buy	3,267 +924	+39%	+$440K	0.19%	108
2022 Q4	$1.2M	Sell	2,343 -358	-13%	-$182K	0.19%	116
2022 Q3	$1.23M	Buy	2,701 +20	+0.7%	+$9.57K	0.16%	136
2022 Q2	$1.29M	Buy	2,681 +155	+6%	+$76.7K	0.17%	133
2022 Q1	$1.24M	Buy	2,526 +62	+3%	+$28.3K	0.11%	174
2021 Q4	$1.14M	Buy	+2,464	New	+$1.04M	0.1%	187

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Desjardins Global Asset Management's ELV Position: Q4 2023 in Review

Desjardins Global Asset Management increased its Elevance Health (ELV) stake by 1.1% in Q4 2023, buying an estimated $20.3K and bringing the position to 3,922 shares worth $1.85M. The position accounts for 0.2% of the portfolio, ranked #123.

Desjardins Global Asset Management first reported a position in ELV in Q4 2021 and has held it in 9 quarters since. 1,655 funds tracked by Wall St. Rank hold ELV as of Q4 2023.

Desjardins Global Asset Management held 3,922 shares of Elevance Health worth $1.85M as of Q4 2023.
Desjardins Global Asset Management bought 44 Elevance Health shares in Q4 2023, an estimated $20.3K.
Elevance Health made up 0.2% of Desjardins Global Asset Management's portfolio in Q4 2023, its #123 holding.
Desjardins Global Asset Management first reported a position in Elevance Health in Q4 2021 and has held it in 9 quarters since.
1,655 funds tracked by Wall St. Rank held Elevance Health as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.